Beacon Diagnostics® Laboratory, specializing in (1→3)-β-D-glucan testing as an aid in the diagnosis of invasive fungal infection, is a CLIA-certified reference laboratory.  The laboratory, directed by Richard C. Tilton, Ph.D., is a division of Associates of Cape Cod, Inc. The expert staff at Beacon Diagnostics laboratory provides clients with rapid diagnostic and analytical service, to assist in the medical evaluation of patients suspected of having invasive fungal infections.

Information concerning the applications and latest findings of (1→3)-β-D-glucan testing in patients is available on this website. In addition, links are provided to other websites of interest to the mycotic disease community.

Immune suppressed patients are at high risk for developing invasive fungal infections, which are typically difficult to isolate and diagnose. Affected patient populations include:
1. Cancer patients undergoing chemotherapy
2. Stem Cell and Organ Transplant patients
3. Burn patients
4. HIV patients
5. ICU patients

Hours of Operation
Testing: Monday-Friday, 8:00 a.m. to 5:00 p.m. EST
Sample Receiving: Monday-Saturday, 8:00 a.m. to 7:00 p.m. EST

Beacon Diagnostics® Laboratory
124 Bernard E. Saint Jean Drive
East Falmouth, MA 02536-4445, USA

For technical information and sample
submission call:
(800) 568-0058
(508) 444-1481 (fax)
Email: beacondiagnostics@acciusa.com

For all other inquiries contact:
Amy B. Charlonne
Clinical Diagnostic Consultant
Tel: (508) 685-8715
Email: Acharlonne@acciusa.com

 

Aside from our CLIA license, Beacon Diagnostics now has licensure in New York, Florida, Maryland, Pennsylvania, Rhode Island, California and Massachusetts. License application for New Jersey has been filed and is currently pending. Other states not listed here do not have separate licensure requirements and, therefore, are already being served by Beacon Diagnostics. If you would like to send samples to Beacon Diagnostics but are currently located in New Jersey, please call us at (800) 568-0058. This state may have an exception policy which will allow you to send in samples while our license is pending.

Introducing the Fungitell® Assay
The Fungitell® assay, manufactured by Associates of Cape Cod, Inc., detects (1→3)-β-D-glucan, a cell wall component of most medically important fungi including Candida and Aspergillus. Beacon Diagnostics laboratory uses the Fungitell assay to provide clinicians with vital information that can aid in early diagnosis of invasive fungal infection.